| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
2 |
? － ? |
Ofloxacin (Floxin)  |
341 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
4 |
0.008 － 4 |
Cefixime (Suprax) |
287 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
4 |
? － ? |
Gatifloxacin (Tequin) |
1044 |
| Streptococcus pneumonia (penicillin-susceptible) |
>=- |
≥8 |
? － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1044 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
8 |
? － ? |
Levofloxacin (Levaquin, Quixin) |
1044 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
16 |
1 － 256 |
Clavulanate |
287 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
- |
≤0.06 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
452 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
- |
0.25 － ? |
Tosufloxacin |
963 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
- |
0.5 － ? |
Sparfloxacin (AT-4140, Zagam) |
963 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
- |
1 － ? |
Levofloxacin (Levaquin, Quixin) |
963 |
| Streptococcus pneumonia (penicillin-susceptible) |
- |
- |
2 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
963 |
| Streptococcus pneumonia (polymyxin B-resistant) |
- |
- |
≥4 － ? |
Polymyxin B (Aerospin) |
452 |
| Streptococcus pneumonia (polymyxin B-susceptible) |
- |
- |
≤2 － ? |
Polymyxin B (Aerospin) |
452 |
| Streptococcus pneumonia (preclinical isolate + pencillin-intermediate) |
0.25 |
16 |
≤0.06 － >=128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-intermediate) |
0.5 |
0.5 |
≤0.06 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-intermediate) |
0.5 |
1 |
≤0.06 － 2 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-intermediate) |
1 |
2 |
0.12 － 8 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-resistant) |
0.25 |
1 |
≤0.06 － 2 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-resistant) |
0.25 |
8 |
≤0.06 － >=128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-resistant) |
0.5 |
0.5 |
≤0.06 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-resistant) |
1 |
2 |
0.5 － 4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-susceptible) |
0.25 |
0.25 |
≤0.06 － >=128 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-susceptible) |
0.25 |
0.5 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-susceptible) |
0.5 |
0.5 |
≤0.06 － 1 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Streptococcus pneumonia (preclinical isolate + pencillin-susceptible) |
0.5 |
1 |
≤0.06 － 4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Streptococcus pneumonia (PW3) |
- |
- |
1.2 － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
33 |
| Streptococcus pneumonia (PW3) |
- |
- |
1.2 － ? |
RU79115 |
33 |
| Streptococcus pneumonia (quinolone-resistant) |
0.06 |
0.12 |
0.004 － 0.5 |
ABT-492 |
3 |